Catheter Precision Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
-$19.00next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 16 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Growth Quarterly20,000.0%Target: Maintain triple-digit year-over-year growth driven by segment diversification
Aviation Segment Revenue Contribution Quarterly184KTarget: Scale short-haul Northeast routes and expand to international destinations
Medical Device Segment Divestiture Progress MonthlyTarget: Complete formal marketing and sale of cardiac electrophysiology assets (VIVO and LockeT)
Watch Items
- Going Concern and Cash RunwayTrigger: Cash and cash equivalents falling below $0.1 million without secured financingAction: Execute additional capital raises or draw down on the $36.5 million strategic institutional financing facility.
- Integration of Flyte and Fleet ExpansionTrigger: Delays in deploying additional Cirrus Vision Jets or regulatory hurdles in international route expansionAction: Reallocate capital from legacy medical operations to support regional air mobility infrastructure.
- Monetization of Cardiac Electrophysiology PortfolioTrigger: Failure to secure a strategic buyer for VIVO and LockeT assets within 12 monthsAction: Re-evaluate asset valuations or restructure licensing/royalty agreements to optimize shareholder value.
Research as of 20 Jun 2026